Skip to main content
Learn

How does tirzepatide work?

Educational content, not medical advice

Tirzepatide is a dual GIP and GLP-1 receptor agonist: Coskun and colleagues reported in Molecular Metabolism that it activates both gut-hormone receptors involved in appetite and glucose signaling. Compounded tirzepatide is not FDA-approved. A licensed clinician reviews your history, can say no, and if prescribed a U.S. pharmacy ships to all 50 states.

Start a consult See a licensed clinician
Rx only · a licensed clinician determines appropriateness and may decline · compounded medications are not FDA-approved
How does tirzepatide work?
How does tirzepatide work?

How does tirzepatide work?

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Coskun and colleagues reported in Molecular Metabolism (2018) that the peptide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. That dual-receptor design is the mechanism. Compounded tirzepatide is not FDA-approved.

GIP and GLP-1 are gut hormones involved in appetite and blood-sugar signaling. Compounded tirzepatide injection is listed at $339 per 4 weeks. Compounded products are prepared for an individual patient by a licensed U.S. 503A pharmacy; the FDA states they do not undergo premarket review for safety, effectiveness, or quality. PinwellRx is nationwide telehealth with Houston as HQ and ships to all 50 states. A licensed clinician can still say no. Full refund if you are not prescribed. See also What is compounded tirzepatide?.

Semaglutide is a GLP-1 receptor agonist, one gut-hormone signal, not dual. How does semaglutide work?

How does oral semaglutide work?

An oral tablet can still be a GLP-1 receptor agonist. Buckley and colleagues reported in Science Translational Medicine (2018) that a derivatized GLP-1 receptor agonist can be absorbed from the stomach as a tablet. The receptor target is the same class of signal; the route is oral. Compounded oral semaglutide is not FDA-approved.

Oral semaglutide tablets are listed at $279 per 4 weeks. Compounded oral tablets are not the same as an FDA-approved oral GLP-1 product and have not been reviewed by the FDA for safety or effectiveness. Whether a tablet is appropriate for you is a clinical decision. The clinician can say no. Mechanism of the injectable is covered on How does semaglutide work?.

What is a GLP-1 microdose?

A microdose is a lower starting amount of the same receptor signals used in compounded GLP-1 or dual GIP and GLP-1 therapy. It is still a prescription medication, not a supplement. A licensed clinician decides whether a microdose is appropriate and may decline.

Semaglutide microdose is listed at $179. Tirzepatide microdose is listed at $179. Lower starting amounts do not make these products over-the-counter, and they remain compounded medications that are not FDA-approved. PinwellRx does not apply branded-trial percentages to compounded products. Nationwide telehealth; Houston is HQ; ships to all 50 states.

Related options

Weight-management catalog, with the price on it.

Rx only. A licensed clinician determines appropriateness and may decline. Compounded medications are not FDA-approved. You see your price before you pay.

Compounded tirzepatide injection$339 / 4 wk
Compounded semaglutide injection$249 / 4 wk
Oral semaglutide tablets$279 / 4 wk
Semaglutide microdose$179
Tirzepatide microdose$179

All medications are compounded by licensed U.S. 503A pharmacies and are not FDA-approved. Prescription only. A licensed clinician determines appropriateness and may decline; full refund if not prescribed. Individual results vary. For education, not medical advice.

Keep reading
What is compounded tirzepatide? How does semaglutide work? Is compounded tirzepatide safe? How do you get compounded tirzepatide? What is NAD+? What does PinwellRx offer?

Find out what a clinician would say.

Ten minutes of honest questions. A licensed clinician reviews, and can say no. Full refund if you are not prescribed.

Start a consult See a licensed clinician
Reviewed by the PinwellRx clinical team · Updated August 2026
Sources
Coskun et al., Molecular Metabolism (2018). Dual GIP and GLP-1 receptor agonist. DOI 10.1016/j.molmet.2018.09.009. PMID 30473097. Drucker, Cell Metabolism (2018). GLP-1 slows gastric emptying and promotes satiety. DOI 10.1016/j.cmet.2018.03.001. PMID 29617641. Buckley et al., Science Translational Medicine (2018). Oral GLP-1 receptor agonist absorption. DOI 10.1126/scitranslmed.aar7047. PMID 30429357. FDA: Human Drug Compounding, Questions and Answers FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Cited pages are the authorities on mechanism, compounding, and approval status. PinwellRx is the authority only on its own process and pricing. Compounded medications are not FDA-approved.
Start a consult